MNPR

Monopar Therapeutics Inc.

Price

$123.84

return (12m)

269.56%

p/e

-55.49

p/bv

7.57

DIVIDEND YIELD

0.00%

MNPR price

Monopar Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MNPR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.20%

3 months

98.10%

1 year

269.56%

2 years

5,103.36%

5 years

431.50%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals MNPR

Valuation

P/E

-55.49

Sector -4.38

Industry -4.38

P/BV

7.57

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-128.66

Sector -263.09

Industry -263.09

EV/EBIT

-128.66

Sector -702.90

Industry -702.90

P/EBITDA

-44.73

Sector -4.39

Industry -4.39

P/EBIT

-44.73

Sector -4.73

Industry -4.73

P/Total Assets

7.33

Sector 1.49

Industry 1.49

P/Net Current Assets

7.58

Sector -11.70

Industry -11.70

P/Working Capital

7.57

Sector -3.19

Industry -3.19

EPS

-1.98

Sector -2.14

Industry -2.14

BVPS

14.54

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-13.63%

Sector -65.14%

Industry -65.14%

ROA

-13.22%

Sector -65.53%

Industry -65.53%

ROIC

-11,683.52%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

33.52

Sector 2.90

Industry 2.90

Net Debt / EBITDA

20.20

Sector -6.07

Industry -6.07

Net Debt / EBIT

20.20

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.03

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.97

Sector 0.41

Industry 0.41

Liabilities/Assets

0.03

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

14.41%

Sector -

Industry -

Fundamentals MNPR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MNPR Monopar Therapeutics Inc.	$123.84	261.47%	0.00%	-55.49	7.57	-13.63%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MNPR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Monopar Therapeutics

Monopar Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2019

Time since IPO - 7 years

10

Employees

Monopar Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $989.91 million, with shareholders equity totaling $130.85 million.

The company employs approximately 10 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Monopar Therapeutics Inc. reported $- in revenue, generating net income of $-17.84 million.

Key financial metrics include a P/E ratio of -55.49, a price-to-book (P/B) ratio of 7.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MNPR.

Market cap

$989.91 million

Net worth

$130.85 million

$130,850,000.00

Assets

$134.98 million

$134,980,000.00

Total Shares Outstanding

9.00 million

9,000,000

Average Daily Trading Volume

$230.87 Thousand

$230,872.00

Sector

Health Care

Industry

Biotechnology

MNPR

MNPR revenue and profits

Financial Results MNPR

DRAG THE FRAME TO SEE MORE DATA

MNPR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Monopar Therapeutics (MNPR) today?

A cotação de Monopar Therapeutics (MNPR) hoje está em US$ 123.84, com uma variação de 269.56% em relação ao último ano. A cotação de Monopar Therapeutics (MNPR) iniciou o ano negociando na casa dos US$ 65.30 e hoje está em US$ 123.84. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Monopar Therapeutics (MNPR) e dados de ações do Ibovespa e mercados internacionais.

Quando Monopar Therapeutics (MNPR) paga dividendos?

Monopar Therapeutics (MNPR) não distribuiu dividendos no último ano.

Is Monopar Therapeutics (MNPR) a good investment?

Atualmente, Monopar Therapeutics (MNPR) está cotada a US$ 123.84, com um P/L de -55.49, representando um desvio de -2,197% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 269.56 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 269.56%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Monopar Therapeutics (MNPR) stock?

Investir em ações de Monopar Therapeutics (MNPR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Monopar Therapeutics (MNPR) yield today?

A rentabilidade de Monopar Therapeutics (MNPR) foi de 13.20% no último mês, 269.56% no último ano e 431.50% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Monopar Therapeutics (MNPR) hoje, o investimento total seria de US$ 12,384.00, com base na cotação atual de US$ 123.84.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 45,766.31
Em 5 anos: US$ 65,820.96
Em 10 anos: US$ 12,384.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MNPR

Monopar Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MNPR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MNPR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Monopar Therapeutics

Monopar Therapeutics Inc.

United States

11 years

2019

10

PROFIT X PRICE MNPR

Financial Results MNPR

MNPR cash flow

Asset, Revenue and Profit Growth - MNPR

MNPR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions